Clearance receptors and endopeptidase: Equal role in natriuretic peptide metabolism in heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 42, Issue 5, 1997, Pages

  Rademaker, Miriam Tessa ^a   Charles, Christopher John ^a   Kosoglou, Teddy ^a   Frotter, Andrew A ^a   Espiner, Eric Arnold ^a   Nicholls, Michael Gary ^a   Richards, Arthur Mark ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Guanosine 3',5' cyclic monophosphate; Hemodynamics; Natriuresis; Ventricular pacing

Indexed keywords

EID: 33751299326     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Abassi, Z. A., S. Kotob, E. Colomb, F. Pieruzzi, and H. R. Keiser. Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure. Hypertension 25: 1178-1184,1995.
2. Aitken, G. D., P. George, and E. A. Espiner. Characterisation of ovine natriuretic peptide genomic DNA sequences (Abstract). J. Hypertens. 12, Suppl. 3:174,1994.
3. Anand-Srivastava, M. B., J. Gutkowska, and M. Cantin. The presence of atrial-natriuretic-factor receptors of ANF-R2 subtype in rat platelets. Biochem. J. 278:211-217,1991.
4. Brandt, R. R., M. M. Redfield, L. L. Aarhus, J. A. Kewicki, and J. C. Burnett. Clearance receptor-mediated control of atrial natriuretic factor in experimental congestive heart failure. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R936-R943,1994.
5. Cahill, P. A., and A. Hassid. Clearance receptor binding atrial natriuretic peptide inhibits mitogenesis and proliferation of rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 179:1606-1613,1991.
6. Cavero, P. G., K. B. Margulies, J. Winaver, A. A. Seymour, N. G. Delaney, and J. C. Burnett. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. Circulation 82:196-201,1990.
7. Charles, C. J., E. A. Espiner, M. G. Nicholls, A. M. Richards, T. G. Yandle, A. Frotter, and T. Kosoglou. Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep. Am. J. Physiol. 271 (Regulatory Integralive Comp. Physiol. 40): R373-R380,1996.
8. Chiu, P. J. S., G. Tetzloff, M. T. Romano, C. J. Foster, and E. J. Sybertz. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats. Am. J. Physiol. 260 (Regulatory Integrative Comp. Physiol. 29): R208-R216,1991.
9. Espiner, E. A., A. M. Richards, T. G. Yandlc, and M. G. Nicholls. Natriuretic hormones. Endocrinol. Metab. Clin. North Am. 24:481-509,1995.
10. Fitzpatrick, M. A., M. G. Nicholls, E. A. Espiner, H. Ikram, P. Bagshaw, and T. G. Yandle. Neurohumoral changes during onset and ofiset of ovine heart failure: role ofANP. Am. J. Physiol. 256 (Heart Circ. Physiol. 25): H1052-H1059,1989.
11. Fitzpatrick, M. A., M. T. Rademaker, C. M. Frampton, C. J. Charles, T. G. Yandle, E. A. Espiner, and H. Ikram. Hemodynamic and hormonal effects of renin inhibition in ovine heart failure. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H1625H1631,1990.
12. Hashimoto, Y., K. Nakao, N. Hama, H. Imura, S. Mori, M. Yamaguchi, M. Yasuhara, and R. Hori. Clearance mechanisms of atrial and brain natriuretic peptides in rats. Pharm.Res. 11:60-64,1994.
13. Hu, R. M., E. R. Levin, A. Pedram, and H. J. Frank. Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. Mediation through the C-receptor. J. Biol. Chem. 267:17384-17389,1992.
14. Kenny, A. J., A. Bourne, and J. Ingram. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem. J. 291:83-88,1993.
15. Kishimoto, I., K. Nakao, S.-I. Suga, K. Hosoda, T. Yoshimasa, H. Itoh, and H. Imura. Downregulation of C-receptor by natriuretic peptides via ANP-B receptor in vascular smooth muscle cells. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H1373-H1379,1993.
16. Kukkonen, P., O. Vuolteenaho, and H. Ruskoaha. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39370, an endopeptidase inhibitor, and C-ANFC4-23), a clearance receptor ligand. Endocrinology 130: 755-765,1992.
17. Mukoyama, M., K. Nakao, K. Hosoda, S. Suga, Y. Saito, Y. Ogawa, G. Shirakami, M. Jougasaki, K. Obata, and H. Yasue. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J. Clin. Invest. 87:1402-1412,1991.
18. Munzel, T., S. Kurtz, J. Holtz, R. Busse, H. Steinhauer, H. Just, and H. Drexler. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure. Circulation 86: 1089-1098,1992.
19. Nakao, K., Y. Ogawa, S. Suga, and H. Imura. Molecular biology and biochemistry of the natriuretic peptide system. II. Natriuretic peptide receptors. J. Hypertens. 10:1111-1114,1992.
20. Norman, J. A., D. Little, M. Böiger, and G. di Donato. Degradation of brain natriuretic peptide by neutral endopeptidase: species specific sites of proteolysis determined by mass spectrometry.Biochem. Biophys. Res. Commun. 175:22-30,1991.
21. Pcrrella, M. A., L. L. Aarhus, D. M. Heublein, J. A. Lewicki, and J. C. Burnett. Biological role of atrial natriuretic factor clearance receptor in congestive heart failure. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H401-H408,1993.
22. Rademaker, M. T., C. J. Charles, E. A. Espincr, C. M. Frampton, M. G. Nicholls, and A. M. Richards. Comparative bioactivity of atrial and brain natriuretic peptides in an ovine model of heart failure. Clin. Sei. (Land.) 92:159-165,1997.
23. Rademaker, M. T., C. J. Charles, E. A. Espiner, M. G. Nicholls, A. M. Richards, and T. Kosoglou. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure. Clin. Sei. (Land.) 91: 283-291,1996.
24. Schiffrin, E. L. Regulation of receptors for atrial natriuretic peptide in the rat and human. Cardiova.sc. Drugs Ther. 2: 493-500,1988.
25. Seymour, A.A., B. E.Abboa-Offei, P. L. Smith, P. D. Mathers, M. M. Asaad, and W. L. Rogers. Potentiation of natriuretic peptides by neutral endopeptidase inhibitors. Clin. Exp. Pharmacol. Physiol. 22: 63-69,1995.
26. Seymour, A. A., M. M. Asaad, V. M. Lanoce, K. M. Langenbacher, S. A. Fennell, and W. L. Rogers. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure. J. Pharmacol. Exp. Ther. 266:872-883,1993.
27. Shima, M., Y. Seino, S. Torikai, and M. Imai. Intrarenal localization of degradation of atrial natriuretic peptide in glomeruli and cortical nephron segments. Life Sei. 43: 357-363, 1988.
28. Sybertz, E. J. SCH 34826: an overview of its profile as a neutral endopeptidase inhibitor and ANF potentiator. Clin. Nephrol. 36: 187-191,1991.
29. Vemulapalli, S., P. J. S. Chiu, K. Griscti, and E. J. Sybertz. The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANP(4-23) in DOCAsalt hypertensive rats. Life Sei. 49: 383-391,1991.
30. Wegner, M., C. Hirth-Dietrich, and J. P. Stasch. Role of neutral endopeptidase 24.11 in AV fistula rat model of heart failure. Cardiovasc. Res. 31:891-898,1996.
31. Wegner, M., J.-P. Stasch, C. Hirth-Dietrich, J. Dressel, K.-P. Voges, and S. Kazda. Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs. Clin. Exp. Hypertens. 17:861-876,1995.
32. Yandle, T., M. Smith, E. Espiner, M. Richards, and G. Nicholls. Natriuretic peptide receptors in sheep lung and adrenal tissue (Abstract). Endocrine Soc. Aust. Proc. 38: NZ20,1995.
33. Yasuhara, M., M. Yamaguchi, H. Shimizu, Y. Hashimoto, N. Hama, H. Itoh, K. Nakao, and R. Hori. Natriuretic peptidepotentiating actions of neutral endopeptidase inhibition in rats with experimental heart failure. Pharm. Res. 11: 1726-1730, 1994.